Page last updated: 2024-08-26

lupenone and Diabetes Mellitus, Type 2

lupenone has been researched along with Diabetes Mellitus, Type 2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Wang, X; Wang, Y; Wu, H; Xu, F; Yang, Y; Zhang, M1
Huang, X; Kong, J; Li, X; Wang, X; Wu, H; Xu, F; Yang, X; Yu, P; Zhang, L; Zhen, C1

Other Studies

2 other study(ies) available for lupenone and Diabetes Mellitus, Type 2

ArticleYear
Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology.
    Pharmaceutical biology, 2022, Volume: 60, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Insulin; Insulin Resistance; Male; Network Pharmacology; Rats; Rats, Sprague-Dawley; Triterpenes

2022
Lupenone improves type 2 diabetic nephropathy by regulating NF-κB pathway-mediated inflammation and TGF-β1/Smad/CTGF-associated fibrosis.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 118

    Topics: Animals; Anti-Inflammatory Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Eosine Yellowish-(YS); Fibrosis; Hematoxylin; Inflammation; Kidney; Mice; NF-kappa B; Proteinuria; Rats; Transforming Growth Factor beta1

2023